Healthcare & Life Sciences
Stoke Therapeutics
United Stateswww.stoketx.com
Stoke Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Stoke Therapeutics
Stoke Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Stoke Therapeutics is a clinical-stage biotechnology company developing genetic medicines that increase protein production from healthy genes by modulating RNA splicing using antisense oligonucleotides, targeting rare genetic diseases such as Dravet syndrome and autosomal dominant optic atrophy.
Explore Stoke Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.